跳至主要内容
临床试验/NCT03949543
NCT03949543已完成不适用

A Randomised Controlled Trial of Meal Timing as an Acute Modifier of the Gut Microbiota and the Cardiometabolic Health of the Host.

University of Glasgow2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2017年10月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Faecal short chain fatty acids

研究概览

简要总结

The interplay between diet and the gut microbiota has been implicated in the onset of cardiovascular disease. The gut microbiota displays diurnal rhythms, which may be influenced by meal timing. This study aimed to investigate the effect of main meal consumption timing on the microbiota and the cardiometabolic factors of the host using a cross-over RCT in healthy adults

The main outcome measurements will be: a) changes in gut microbiota composition based on 16S rRNA gene amplicon sequencing and shotgun metagenomics, b) changes in bacterial functional capacity) and urinary/faecal metabolomics, c) changes in targeted bacterial metabolites, d)Inflammatory markers

The aim of this study is to explore the effect of the timing of main meal consumption on gut microbiota and immune response in healthy adults.

详细描述

This study will be an open-label, cross-over RCT in healthy adults. Healthy adult (>18 y) participants will be recruited from the community by means of an advertisement leaflet (see associated supporting document-"Advertisement flyer") and word of mouth. The researcher will arrange a meeting with those expressing an interest about the study. The researcher will collect demographic information (e.g. age and gender) and ask the subjects whether they suffer from any acute or chronic illness (defined as illness which requires regular visits to health services) (see associated supporting document-"Health Questionnaire"). If they suffer from a chronic illness they will be excluded. Other exclusion criteria include history of previous of major gut surgery, unstable weight, use of antibiotics or steroids the last 3 months. Participants will be informed about the study at Human Nutrition, New Lister Building, Glasgow Royal Infirmary, or at the University of Glasgow main campus social areas (e.g. Gilchrist). No children will be recruited. Subjects who have expressed an interest about the study but are not suitable to participate will be acknowledged and will receive an explanation as to why they have been excluded.

Following informed written consent, participants will be randomly allocated to intervention groups using the MS Excel "rand()" function. Women will start their intervention on the same phase of their menstrual cycle to avoid the effect of hormonal changes on study outcome.

Dietary interventions: Participants will be asked to undertake two experimental diets. The two dietary interventions are identical with the only difference being the timing of the main meal consumption (dinner and lunch). Participants will follow each diet for a period of one week with a three week washout period between the two interventions. The wash out period aims to drive the gut microbiota characteristics back to baseline levels. The diet will provide the average energy requirements of the participants (Department of Health) and aims to keep participants' weight stable during the study period. All dietary aspects of the study will be designed and supervised by the qualified dietitians/nutritionists, who are members of the research team. Participants will be given a list of meals and snacks to choose from (see associated supporting document-"Food List Preferences"). All meals will be provided to the participants free of charge. Meals will be ordered online by the researchers, using the University of Glasgow Hub, and will be delivered to the participants' residence by the supermarket staff. Weight and height will be measured.

Week 1 Participants will follow a structured diet containing meals of their choice for a week. The participants will select these meals from a list which the researcher will provide to them. The timing of the meal will be specified and the participants will have to complete their meals within 25±5 minutes. The participants will be given written instructions on how to follow the diet (see associated supporting document-"Instruction Sheet" & "Participant Study Calendar"). Participants will provide all faecal samples produced during days from noon of day 5 to noon of day 8. Fasted blood (6 ml) and urine samples will be collected the day after the end of the Week 1 intervention (i.e. day 8). These will be collected at the Human Nutrition laboratory, at the New Lister Building, Glasgow Royal Infirmary. Weight and height measurements will be repeated.

Week 2, 3 & 4 During the wash out period, the participants will follow their habitual diet and no research intervention will take place.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adult people

排除标准

  • History of gut surgery
  • Use of antibiotics or steroids the last 3 months
  • Positive or negative energy balance (recent weight gain or loss, ±2 Kg the past month)

研究组 & 干预措施

Healthy Adult Participants A

Experimental

Participants who will get two interventional diets, for 7 days each, but allocated to start with large lunch intervention

干预措施: Large Lunch Intervention (Other)

Healthy Adult Participants A

Experimental

Participants who will get two interventional diets, for 7 days each, but allocated to start with large lunch intervention

干预措施: Large Dinner Intervention (Other)

Healthy Adult Participants B

Experimental

Participants who will get two interventional diets, for 7 days each, but allocated to start with large dinner intervention

干预措施: Large Lunch Intervention (Other)

Healthy Adult Participants B

Experimental

Participants who will get two interventional diets, for 7 days each, but allocated to start with large dinner intervention

干预措施: Large Dinner Intervention (Other)

结局指标

主要结局

Faecal short chain fatty acids

时间窗: 7 days post-intervention

Short chain fatty acids (umol/g)

Gut microbiome alpha diversity

时间窗: 7 days post-intervention

Shannon diversity index

次要结局

  • IL-6(7 days post-intervention)
  • tnf alpha(7 days post-intervention)
  • Triglycerides(7 days post-intervention)
  • Glucose(7 days post-intervention)
  • HDL(7 days post-intervention)
  • LDL(7 days post-intervention)
  • Insulin(7 days post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Konstantinos Gerasimidis

Senior Lecturer in Clinical Nutrition

University of Glasgow

研究点 (2)

Loading locations...

相似试验